Evidence map›Paper›PMID 40599262›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2025

[High-resolution Differential Proteomic Analysis of Mouse Secondary Oocytes and First Polar Bodies].

Xiaodan Fan, Liming Zhou

Abstract readEnglish Abstract
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaodan Fan( 315000) Health Science Center, Ningbo University, Ningbo 315000, China.
Liming Zhou( 315000) Health Science Center, Ningbo University, Ningbo 315000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To analyze the proteomic differences between mouse secondary oocytes, also known as metaphase Ⅱ oocytes (MⅡ), and the first polar bodies (PB1) using high-resolution single-cell proteomics, to identify key proteins regulating embryonic development, and to provide a molecular basis for optimizing Methods: Paired samples of MⅡ ( Results: Using the timsTOF HT platform, we achieved the detection of over 3000 proteins per single cell and identified 277 proteins specifically enriched in MⅡ. Gene Set Enrichment Analysis (GSEA) revealed that these MⅡ-specific proteins were significantly enriched in gene regulation and DNA damage repair pathways associated with mitochondrial energy metabolism. Cross-species GSEA comparison between human and mouse homologs demonstrated elevated expression of heat shock proteins, including Hsp90b1, Hspa5, etc., in the mTORC1 pathway in MⅡ ( Conclusion: MⅡ strategically retains proteins essential for embryonic development through asymmetric division. The timsTOF HT platform demonstrated superior sensitivity in analyzing and identifying these proteins. According to the protein analysis results, the distribution of mTORC1 pathway proteins indicates that they play a key role in embryonic metabolism regulation. In particular, heat shock proteins facilitate protein folding and maintain endoplasmic reticulum homeostasis, thereby ensuring oocyte maturation and the embryonic developmental potential.

Indexed as

OocytesPolar BodiesProteomeProteomicsAnimalsEndoplasmic Reticulum Chaperone BiPFemaleMiceEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanHspa5 protein, mouseProteomePolar bodyProteomicsSecondary oocyteSingle-cell oocyte

Identifiers

PMID40599262
PMCPMC12207035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.